We found that the effect was largely attributable to the MS and ID groups, with consistent effects of the top clone-defining genes (e.g., SUB1, CAPZB, and ARPC5) in both MS and ID expanded CSF memory cells (Tables S7 and S12). This evidence concerns the gene CAPZB and myeloid sarcoma.